Neuroscience

Team finds melatonin delays ALS symptom onset and death in mice

Melatonin injections delayed symptom onset and reduced mortality in a mouse model of the neurodegenerative condition amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to a new study by researchers at ...

Neuroscience

Study offers new approach for spinal muscular atrophy

Spinal muscular atrophy is a debilitating neuromuscular disease that in its most severe form is the leading genetic cause of infant death. By experimenting with an ALS drug in two very different animal models, researchers ...

Genetics

A fly mutation suggests a new route for tackling ALS

A team of researchers, led by Marc Freeman, PhD, an early career scientist with the Howard Hughes Medical Institute and associate professor of neurobiology at the University of Massachusetts Medical School have discovered ...

Neuroscience

Lithium shows no benefit to MND patients

(Medical Xpress)—Results from a clinical trial into amyotrophic lateral sclerosis (ALS), led by King's College London's Institute of Psychiatry show that lithium carbonate is ineffective at treating the disease.

Neuroscience

Researcher advancing motor neuron studies

A University of Connecticut researcher is advancing the understanding of the devastating inherited condition known as spinal muscular atrophy.

page 24 from 31